Organization (Government)
Ministry of Health
ClinicalTrials.gov lists Ministry of Health as lead sponsor of 212 trials, counting the companies grouped under it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section
17 sections measured, none recorded
This page covers Ministry of Health and 6 companies grouped under it: 212 lead-sponsored trials (0 its own, 212 in the grouped companies) and 58 legal-entity registrations (51 its own, 7 in the grouped companies).
Companies grouped under this page (6)
Shown in this order: most lead trials first.
| Company | Lead trials | Legal entities |
|---|---|---|
| Ankara Etlik City Hospital | 168 | 1 |
| Fraser Health | 36 | 1 |
| Na Homolce Hospital | 5 | 1 |
| Vabiotech (Vietnam) | 2 | 1 |
| Island Health | 1 | 1 |
Showing 5 of 6 member companies.
Disease areas (3)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Acute Disease | 1 |
| Diabetes Mellitus | 1 |
| Diabetes Mellitus, Type 1 | 1 |
Trials by start year as sponsor or collaborator (2)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2009 | 1 |
| 2002 | 1 |
No forecast is made for this organization: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
Journals published in (6)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| BMJ (Clinical research ed.) | 5 |
| Diabetes care | 3 |
| JAMA | 1 |
| Pediatrics | 1 |
| The Cochrane database of systematic reviews | 1 |
Showing 5 of 6 journals.
Organization relationships (1)
| Related organization | Relationship | Evidence |
|---|---|---|
| Erasmus Medical Center | Co sponsors trial with | 1 |
Latest dated events (2)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2009-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2002-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Biomarker capability evidence (2)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| GAD2 | Trial collaborator | Named in trial inclusion criteria |
| GAD2 | Trial collaborator | Mentioned in trial text |
Not on this page
Checked, with nothing recorded for this organization: related companies not grouped here, active development programs, approved assets, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarkers this organization publishes on.